•  
  •  
  •  
  •  

2026-01-06 00:09:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Mahindra Unveils XUV 7XO: Redefining Premium SUVs with Cutting-Edge Tech and Luxury
  • Algoquant Fintech Ltd commences trading on National Stock Exchange
  • Rajesh Power forays into Battery Energy Storage, Bags 65 MW / 130 MWh BESS Project in Gujarat
  • Polymatech Electronics Pioneers India's First CDSCO-Registered Vein Finder with Indigenous Near-Infrared LED Technology
  • DCX Systems Ltd receives order worth Rs. 11.33 crores

Keywords Selected:  GlenmarkLifeSciences

Stock Report

  • Glenmark Life Sciences rebrands as Alivus Life Sciences
  • Glenmark Life Sciences Ltd posts net profit of Rs. 95.31 crores in Q2 FY2025
  • Glenmark Life Sciences Ltd Q1 FY2025 PAT increases QOQ to Rs. 111.48 crores
  • India Ratings revises Outlook on Glenmark Life Sciences' Bank Loans to Positive, affirms 'IND AA-'
  • Glenmark Life Sciences Ltd Q4 FY2024 PAT declines to Rs. 97.93 crores
  • Nirma Limited acquires majority stake in Glenmark Life Sciences
  • Glenmark Life Sciences Ltd Q3 FY2024 PAT at Rs. 118.76 crores
  • Glenmark Life Sciences announces another CDMO deal
  • Glenmark Life Sciences Limited declares interim dividend of Rs. 22.50
  • Glenmark Pharmaceuticals Ltd to sell stake in Glenmark Life Sciences Ltd to Nirma Ltd
  • Glenmark Life Sciences maintains strong growth momentum, reports robust 25% EBITDA growth in Q1FY24
  • Glenmark Life Sciences Ltd Q4 FY2022-23 PAT soars to Rs. 146.35 crores
  • Glenmark Life Sciences Ltd Q3 FY2022-23 PAT slips to Rs. 104.99 crores
  • Glenmark Life Sciences Ltd Q2FY23 PAT slips to Rs. 106.87 crores
  • Glenmark Life Sciences Ltd Q1FY23 PAT up QoQ at Rs. 108.73 crores
  • Glenmark Life Sciences reports revenue growth of 10% YoY for Q4 FY22, 12.6% for the full year, FY22
  • Glenmark Life Sciences Limited recommends final dividend of Rs. 10.5 for FY22
  • Glenmark Life Sciences reports revenue growth of 4.5% and PAT growth of 11.1% YoY for Q3 FY22

Latest Post

  • Mahindra Unveils XUV 7XO: Redefining Premium SUVs with Cutting-Edge Tech and Luxury
  • Algoquant Fintech Ltd commences trading on National Stock Exchange
  • Rajesh Power forays into Battery Energy Storage, Bags 65 MW / 130 MWh BESS Project in Gujarat
  • Polymatech Electronics Pioneers India's First CDSCO-Registered Vein Finder with Indigenous Near-Infrared LED Technology
  • DCX Systems Ltd receives order worth Rs. 11.33 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025